Sedabarb 30 mg Tablet
PDF Leaflet Revision Date: 10 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylactic treatment of convulsive epilepsy and as a general sedative.
Dosage (summary)
1 tablet twice daily for epilepsy; 1 tablet before bedtime for hypnotic; 1 tablet three times daily for sedative.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use in pregnancy only if benefits outweigh risks; not advisable during breastfeeding due to neonatal sedation risk.
Key Drug Interactions
- Alcohol
- Antidepressants
- Antiepileptics
- Anticoagulants
- Oral contraceptives
Contraindications
- Hypersensitivity to phenobarbitone
- Acute intermittent porphyria
- Severe respiratory depression
- Severe renal or hepatic impairment
Common side effects
- Drowsiness
- Respiratory depression
- Skin reactions
- Cognitive impairment
Counselling Points
- Avoid alcohol
- Monitor for suicidal thoughts
- Use effective contraception
- Do not drive or operate machinery
Serious warnings
- Dependence risk
- Withdrawal syndrome
- Suicidal ideation
- Severe skin reactions (SJS, TEN)
Important Disclaimer
The Sedabarb 30 mg Tablet professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
